Despite the pandemic’s impact, the volume of healthcare private equity transactions accelerated in the latter half of 2020. Now in a new year with a new administration, investors should expect both new opportunities and challenges to emerge in the healthcare sector. To help navigate the evolving landscape, McDermott Will & Emery is dedicating a series of podcast episodes to healthcare private equity. In this first installment, McDermott Partner Krist Werling talks with Brian Fortune, Senior Director at Farragut Square Group, about the top priorities private equity investors should focus on under the Biden administration.
SVB’s annual report found that 2020 was a successful year for healthcare fundraising and investment with neurology leading the way. SVB’s Nooman Haque discusses these findings and provides his insight on the healthcare investment landscape in 2021.
Peloton Equity, LLC (“Peloton”), a healthcare-focused private equity firm, has closed its second fund Peloton Equity II, L.P. (“Fund II”) with $152.25 million in limited partner and general partner commitments. Fund II will seek to continue Peloton’s strategy of investing growth capital in innovative healthcare companies and partnering with management teams to achieve accelerated growth and value creation. Peloton invests across a wide range of healthcare sectors with a focus on differentiated companies that it believes are positioned to benefit from secular industry tailwinds.
It’s no secret that healthcare has been a hot market for investment for quite some time. One area that’s flying under the radar amid record investment in telehealth and virtual care: the employer-sponsored insurance market. Employers themselves were already taking a serious look at ways to shake up the status quo as healthcare costs rise, but the pandemic put a stark spotlight on the need for changes.
The healthcare sector is drawing interest from private equity investors this year, with seven deals announced since Jan. 25, according to this list compiled by Becker’s Hospital CFO Report.
The start of the year has seen continued activity in the ophthalmology vertical, while revenue cycle management companies – particularly those providing solutions to ASCs – are also a focus. Also, we highlight a PE firm with a couple of recent exits.
This Diagnosing Health Care episode dives into the growth of physician practices accepting risk-based payments from health plans and examines why these practices are attractive to investors. Special guest Jason Madden, Managing Director at Accordion, and Epstein Becker Green attorneys Joshua Freemire, Jason Christ, and Tim Murphy, discuss the health regulatory considerations investors must assess when evaluating investment opportunities with physician practices accepting risk-based payments.
Executives from Ares Management and KKR have joined Patient Square Capital, a new healthcare investment firm, as founding partners. Patient Square announced on Monday that Alex Albert, who was most recently the co-head of healthcare private equity at Ares, and Neel Varshney, previously a managing director at KKR’s Americas healthcare private equity team, have joined the firm. Patient Square was launched in August by Jim Momtazee, who spent more than 20 years at KKR. Soon after its launch, the firm sponsored a special-purpose acquisition vehicle called Montes Archimedes Acquisition Corp.
Behavioral health dealmakers have predicted that M&A could reach a new peak in 2021, but some subsectors will see more love than others. Specifically, experts predict that demand for outpatient models and autism services providers will be especially high in the year ahead, with private equity (PE) investors fueling the fire.
There were more than 300 private equity deals in the healthcare industry in 2019, and the healthcare sector has continued to draw private equity investors over the past year. Here are eight private equity deals announced since Jan. 1, per Becker’s Hospital CFO Report.
What We Do
Who We Are
How We Work
Who We Help
Get In Touch
Connect With Us
Subscribe to Our Daily Note
We publish a Daily Note that aggregates M&A activity, notable developments, regulatory changes, and conferences we deem to be of interest to our partners. It is a quick afternoon read and an easy way to keep your finger on the pulse of the healthcare space. Please fill in your name and email address below if you wish to subscribe.